Focusing Treatment on Multiple Pathways to Reduce Resistance and Improve Outcomes in Triple-Positive Breast Cancer
Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.